Skip to main content
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2021 Jul 5;41(11):2674–2683. doi: 10.1038/s41372-021-01136-0

Leveraging the Massachusetts perinatal quality collaborative to address the COVID-19 pandemic among diverse populations

Katherine Sullivan 1,, Mandy B Belfort 2, Patrice Melvin 3, Asimenia Angelidou 4,5, Aviel Peaceman 6, Jessica E Shui 7, Ruben Vaidya 8, Rachana Singh 8,9, Ruby Bartolome 6, Silvia Patrizi 2, Neha Chaudhary 4,10, Ilona Telefus Goldfarb 11, Ivana Culic 4, Diana Yanni 4, Munish Gupta 4, Mark Hudak 12, Margaret G Parker 6
PMCID: PMC8255338  PMID: 34226648

Abstract

Objective

We leveraged the Massachusetts perinatal quality collaborative (PQC) to address the COVID-19 pandemic. Our goals were to: (1) implement perinatal practices thought to reduce mother-to-infant SARS-CoV-2 transmission while limiting disruption of health-promoting practices and (2) do so without inequities attributable to race/ethnicity, language status, and social vulnerability.

Methods

Main outcomes were cesarean and preterm delivery, rooming-in, and breastfeeding. We examined changes over time overall and according to race/ethnicity, language status, and social vulnerability from 03/20-07/20 at 11 hospitals.

Results

Of 255 mothers with SARS-CoV-2, 67% were black or Hispanic and 47% were non-English speaking. Cesarean decreased (49% to 35%), while rooming-in (55% to 86%) and breastfeeding (53% to 72%) increased. These changes did not differ by race/ethnicity, language, or social vulnerability.

Conclusions

Leveraging the Massachusetts PQC led to rapid changes in perinatal care during the COVID-19 crisis in a short time, representing a novel use of statewide PQC structures.

Subject terms: Viral infection, Paediatrics, Scientific community, Health policy

Introduction

The first surge of the SARS-CoV-2 pandemic in the United States (US) occurred from March to June 2020, with the highest prevalence in the Northeast. Hospitals rapidly changed medical care practices to accommodate the influx of patients infected with SARS-CoV-2. In the perinatal setting, hospital teams focused on implementing practices to reduce transmission of SARS-CoV-2 from mother to infant, but faced major challenges in minimizing disruption to existing health-promoting practices. During the early stages of the pandemic, population-level data that may inform optimal perinatal care practices were lacking. For example, in March 2020, the only available data on newborn transmission came from case reports from China where women with SARS-CoV-2 were delivered by scheduled cesarean and separated from their infants after delivery with no direct breastfeeding. While this approach was associated with minimal to no transmission of SARS-CoV-2 to newborn infants [1], it was unclear whether these practices were essential to prevent transmission, or if a similar low risk of transmission could be achieved with perinatal care practices with established health benefits to both mothers and infants [2], such as rooming-in and direct breastfeeding.

Statewide perinatal quality collaboratives (PQC) are networks of perinatal care providers and public health agencies that collaborate to improve outcomes of mother-infant dyads through sharing of ideas, data, and quality improvement [3, 4]. When the SARS-CoV-2 pandemic hit Massachusetts, we leveraged our existing PQC structure to optimize perinatal care for women who tested positive for SARS-CoV-2 and their infants for three main reasons. First, this forum enabled sharing and collaboration among centers to facilitate rapid perinatal practice improvement. Second, PQCs can be most effective when addressing topics with considerable variability in practices [4], which we confirmed after conducting a short survey among clinical leaders of maternity units in Massachusetts from 3/31/20 to 4/5/20. For example, we found large variability in reported approaches to direct breastfeeding (60% of hospitals encouraged breastfeeding with precautions and 28% prohibited or discouraged this practice) [5]. Lastly, we recognized that we could quickly leverage the existing data infrastructure of our PQC, which has been used to evaluate perinatal care practices across sites over time for several years [68].

Evidence of disparities in quality of perinatal care according to race/ethnicity [9, 10] and language status [11] is well-documented and is partly responsible for disparities in perinatal outcomes. Perinatal quality improvement may lead to inadvertent widening or persistence of social disparities [12, 13]. For these reasons, tracking quality measures according to key disparity metrics, such as race/ethnicity, language status, and other social factors is recommended in order for local teams and statewide PQC leadership to adjust their current improvement strategies and/or trial new strategies, if needed, to ensure equitable improvement across all groups [12, 13]. Considering the early evidence in March 2020 that the SARS-CoV-2 pandemic was disproportionately impacting low-income non-Hispanic Black and Hispanic populations, we also aimed to ensure that social factors did not influence implementation of best practices.

In March 2020, the beginning of the SARS-CoV-2 pandemic surge in Massachusetts, we leveraged our PQC to achieve the following project goals: (1) implement perinatal hospital practices thought to reduce mother-to-infant SARS-CoV-2 transmission while limiting disruption of existing health-promoting practices and (2) do so without inequities attributable to race/ethnicity, language status, and social factors. We assessed our outcomes by two complementary data collection strategies. First, through monthly hospital-level surveys of perinatal care practices and second, through individual-level data collection among 11 hospitals that cared for patients living in geographic areas most impacted by SARS-CoV-2 infection [14].

Methods

Population and setting

The Massachusetts Perinatal Neonatal Quality Improvement Network (PNQIN) has conducted several initiatives in the last decade with participation in one or more projects among >80% of its 43 birth hospitals. In this project, hospitals created multi-disciplinary teams and participation was voluntary. State stakeholders included the Department of Public Health, Bureau of Family Health and Nutrition, Betsy Lehman Center for Patient Safety [15], and the Institute for Health and Recovery [16].

We collected data in two ways to understand changes in perinatal practices over time. First, we collected data on hospital-level perinatal care practices by administering three brief (~5–7 min) electronic surveys to clinical leaders previously involved in active PNQIN projects. These surveys were conducted approximately monthly, from March 31-April 5 (survey #1), May 1–5 (survey #2), and May 26–June 8 (survey #3). The surveys were sent to a single clinical leader at each hospital and ascertained current approaches to perinatal care.

To complement the brief hospital practice surveys, a subset of birthing hospitals (7 level 3 and 4 level 2 neonatal care facilities) collected data at the individual mother-infant dyad level by abstracting demographic and clinical data from electronic medical records. These hospitals served patients that lived in cities and towns with high COVID-19 transmission rates. We collected data among women who delivered between March 1 and July 31, 2020 using the American Academy of Pediatrics (AAP) National Perinatal COVID-19 Registry (NPC-19) complemented by a limited Massachusetts-specific perinatal COVID-19 data set. Similar to NPC-19, we included any infant born to a mother with positive SARS-CoV-2 testing 14 days before until 3 days after birth and collected data on maternal severity of illness, birth characteristics, infant SARS-CoV-2 testing during the birth hospitalization, and hospital practices. The Massachusetts data set additionally captured maternal zip code and language status, week of birth, and 30-day post-discharge infant SARS-CoV-2 testing. Both datasets were approved by local institutional review boards of the 11 participating hospitals that contributed dyad-level data and were deemed minimal risk and exempt.

Measures

Hospital-level data captured snapshots of guidelines for maternal and infant SARS-CoV-2 testing procedures, types of personal protective equipment used by neonatal providers at delivery, and approaches to location of care, breastfeeding, skin-to-skin care in the first hour of life, delayed or timed cord clamping, early baths and newborn discharge.

Individual dyad-level data included socioeconomic variables, including maternal race/ethnicity, which we categorized as non-Hispanic white, non-Hispanic black, non-Hispanic Asian, Hispanic of any race, and all others; and maternal language status, which we categorized as English, Spanish, Portuguese or other non-English speaking. We converted zip codes to census tracts using the U.S. Housing and Urban Development’s “Crosswalk Files,” which is endorsed by the Office of Policy Development and Research [17]. In this approach, when a zip code represents more than one census tract, the census tract with the highest residential population is chosen. Census tract was then used to determine degree of social vulnerability according to the Centers for Disease Control (CDC) Social Vulnerability Index (SVI) [18]. In this index, 15 census variables are used to characterize overall social vulnerability and subscales, which include socioeconomic status, household composition, minority status/language, and housing type. We defined “social vulnerability” as >90th percentile on the SVI, according to CDC designated definitions.

Severity of maternal illness with SARS-CoV-2 was categorized as symptomatic vs asymptomatic. We examined plurality, mode of delivery, preterm delivery (<37 weeks’ gestation), and infant weight, sex, and any positive SARS-CoV-2 testing during the birth hospitalization or 30-day post-discharge period. Regarding hospital practices, location of care was categorized as rooming-in at any time vs. complete separation. We categorized infant feeding as any direct breastfeeding vs. none (formula, donor milk, or expressed milk). In this analysis, we targeted direct breastfeeding only, rather than direct breastfeeding or expressed milk given by another way (e.g., bottle, syringe) because of concerns of mother-to-infant SARS-CoV-2 transmission via contact through the process of direct breastfeeding, rather than consumption of expressed milk, where contact was substantially reduced [19].

We derived our main outcomes from individual dyad-level data and sought to capture perinatal hospital practices suspected of increasing mother-to-infant SARS-CoV-2 transmission at the start of our quality initiative. In March 2020, there were concerns that vaginal delivery, rooming-in and direct breastfeeding may increase the likelihood of mother-to-infant SARS-CoV-2 transmission due to close physical con tact [19]. We also hypothesized that preterm delivery may lead to increased transmission in the context of immature immune systems. We additionally examined outcomes according to severity of maternal illness (symptomatic vs. asymptomatic) and important social factors, including maternal underrepresented minority (URM) status (non-Hispanic black or Hispanic vs. all others), maternal language status (English vs. non-English) and significant social vulnerability (SVI > 90th percentile vs. <90th percentile), as we hypothesized that these factors may impact perinatal practices over time.

QI approach

Local multi-disciplinary teams met frequently, developed and updated guidelines on perinatal care, and trialed interventions within their home institutions. We hosted 14 obstetrical and newborn-oriented webinars every 1–3 weeks for all state participants from April to June 2020 [20, 21]. We provided updates on recent publications, emerging data from our own state, existing professional guidance and education on social disparities regarding COVID-19. Several teams shared their experience and/or posted local clinical guidelines on our website which fostered collaboration. We presented findings of our monthly practice surveys and summarized demographic and clinical characteristics of mothers and infants with positive SARS-CoV-2 tests.

Statistical approach

We examined hospital-level practices and described demographic, socioeconomic, and clinical characteristics of individual mother–infant dyads using frequencies (percent) for categorical variables and mean (SD) for continuous variables. We examined differences in our main outcome measures (cesarean and preterm delivery, location of care and direct breastfeeding) according to maternal illness severity, URM and language status, and SVI using Cochran–Mantel–Haenszel χ2 tests to account for clustering by hospital. Statistical process control charts (p-charts) were used to analyze changes over time for our main outcomes. Standard rules were used to identify special cause variation, including eight points above or below the center line, one point beyond outer control limits, and six consecutive points increasing or decreasing [22]. When special cause variation was seen that corresponded to practice changes and was expected to persist, the center lines were shifted. We further examined our main outcomes over time according to severity of maternal illness, maternal URM and language status and SVI using run charts. Due to smaller sample sizes, we collapsed our data to 8 points. A sensitivity analysis of the hospital-level practices among the 11 centers that provided individual-level data showed findings similar to the larger group of hospitals and we therefore present the data from the larger group. All descriptive and statistical analyses were performed using SAS version 9.4 (SAS Institute, Inc, Cary, NC). QI Macros 230 for Excel (KnowWare International, Inc.) was used to create the p-charts.

Results

The median number of individual providers and hospitals that participated in our webinars was 106 (range 43–177) and 26 (range 10–32), respectively. Results of our hospital-level practice surveys administered to clinical leaders at 28 hospitals that were actively involved in a PNQIN project at the time are shown in Table 1. Twenty-eight (100%) responded to survey #1 (early April), 24 (86%) responded to survey #2 (early May), and 18 (64%) responded to survey #3 (early June). Some practices remained consistent over time, such as the use of N95 masks for neonatal staff and restriction to a single support person for pregnant women at delivery (100% throughout the survey periods). Other practices changed markedly. For example, universal testing for asymptomatic women anticipated to deliver increased from 0% in April to 87% in May and 95% in June. Mother–infant separation was reported as the preferred approach for 39% of hospitals in April but decreased to 23% in May and 18% in June. The preferred approach to skin-to-skin care after delivery was reported as prohibited or discouraged in >90% of hospitals in April and May but this decreased to 61% by June. We found that shared decision making was increasingly reported across survey time points as the preferred approach for location of care and direct breastfeeding.

Table 1.

Perinatal COVID-19 Hospital Care Practices in Massachusetts.

Survey #1 3/31-4/5 N = 28 Survey #2 5/1-5/5 N = 24 Survey #3a 5/24-6/8 N = 18
N (%)
Highest level of neonatal care of hospitals
  Level 3 or 4 9 (32%) 9 (37.5%) 8 (44%)
  Level 2 11 (39%) 9 (37.5%) 8 (44%)
  Level 1 8 (29%) 6 (25%) 2 (11%)
Obstetric and Delivery Practices
Testing of Women Anticipated to Deliver
  Universal testing 0% 20 (87%) 17 (94%)
  Testing based on signs and symptoms 26 (93%) 2 (9%) 1 (6%)
  Testing not routinely available for pregnant women n/ab 0 (0%) 0 (0%)
  Other 2 (7%) 1 (4%) 0 (0%)
PPE for COVID-19 positive women delivering vaginally (check all that apply)
  N95 n/ab 23 (100%) 18 (100%)
  Eye protection n/ab 23 (100%) 18 (100%)
  Cap n/ab 17 (74%) 13 (72%)
  Gown n/ab 22 (96%) 18 (100%)
  Gloves n/ab 23 (100%) 18 (100%)
Support persons for pregnant women on Labor and Delivery n/ab
  No support persons n/ab 0 (0%) 0 (0%)
  Only 1 support person n/ab 23 (100%) 18 (100%)
  2 or more support persons n/ab 0 (0%) 0 (0%)
Newborn Care Practices
Location of newborn care with COVID-19 Positive Mother
  Separate room from mother 9 (39%) 5 (23%) 3 (18%)
  Same room as mother with precautions to maintain separation 6 (5%) 5 (23%) 2 (12%)
  Decisions based on shared decision making on a case-by-case basis 13 (43%) 11 (50%) 13 (70%)
  Other 0 (0%) 1 (5%) 0 (0%)
Skin-to-skin care in first hour after birth with COVID-19 Positive Mother
 Prohibited or discouraged 25 (93%) 22 (96%) 11 (61%)
  Encouraged with precautions 2 (7%) 1 (4%) 0 (0%)
  Decisions based on shared decision making on a case-by-case basis n/ab n/ab 7 (39%)
Delayed or timed cord clamping with COVID-19 Positive Motherc
  Yes 12 (44%) 13 (59%) 12 (65%)
  No 11 (41%) 9 (41%) 6 (35%)
  Other 4 (15%) n/ab n/ab
Early baths (<4 h) with COVID-19 Positive Motherd
  Yes 18 (67%) 19 (83%) 13 (72%)
  No 8 (30%) 4 (17%) 5 (28%)
Approach to direct breastfeeding with COVID-19 Positive Mother
  Prohibited 7 (28%) 3 (13%) 0 (0%)
  Discouraged, but permitted if family strongly desires n/a2 14 (58%) 4 (22%)
  Encouraged with precautions 15 (60%) 7 (29%) 1 (6%)
  Decisions based on shared decision making on a case-by-case basis n/a2 n/ab 13 (72%)
Approach to testing for an infant delivered by cesarean section with anticipated discharge on day 3 or 4 with a COVID-19 Positive Mother
  We generally do not test infants 3 (12%)e 3 (13%) 0 (0%)
 Testing is not available for infants 0 (0%) 0 (0%)
  We do 1 test 8 (32%) 7 (29%) 9 (50%)
  We do 2 or more tests 12 (48%) 8 (33%) 9 (50%)
  Other 2 (8%) 6 (25%) 0 (0%)
Discharge Processes for non-COVID-19 Positive Mother-Infant Dyads
Timing of Discharge
  Timing has not really changed n/ab 3 (13%) 2 (11%)
  Some dyads are discharged early n/ab 7 (30%) 7 (39%)
  Many dyads are discharged early n/ab 13 (57%) 9 (50%)
  All dyads discharge early unless a medical contraindication n/ab 0 (0%) 0 (0%)

aSurvey 3 was conducted as part of a national survey of COVID-19 newborn care practices; only results of Massachusetts birth hospitals are presented.

bThis answer choice was not available for this survey.

cIn survey #2 we ascertained that 92% of hospitals perform delayed or timed cord clamping among non-COVID-19 dyads.

dIn survey #3 we ascertained that 0% of hospitals perform early baths among non-COVID-19 dyads.

eIn survey #1 we did not differentiate these responses.

Characteristics of 255 dyads with hospital data and 151 dyads with any post-discharge infant data are shown in Table 2. Among mothers, the majority were URMs (48.2% were Hispanic and 18.8% were non-Hispanic Black), 46% did not speak English and 27% had an overall SVI of >90th percentile, indicating significant social vulnerability. Thirty-one percent had symptomatic infection. Five infants had one or more positive SARS-CoV-2 tests among the 225 that were tested during the hospital period and 1 had a positive test in the 30-day post-discharge period, such that the overall rate of infant positive testing was 2.7% among those tested. Among the 6 infants with positive tests, 1 occurred in March and 5 in April. With respect to our main outcomes, 113/255 (44%) of infants were born by cesarean delivery, 53/255 (21%) were born preterm (of which 15/53 [28%] were spontaneous and 38/53 [72%] were medically-indicated), 167/255 (66%) experienced any rooming-in and 152/255 (60%) were directly breastfed.

Table 2.

Characteristics of 250 mothers with peripartum positive SARS-CoV-2 testing and 255 infants born 3/1/20 to 7/31/20 in Massachusetts.

Participating Hospitals, n (%)
Baystate Medical Center 20 7.8
Beth Israel Deaconess Medical Center 31 12.2
Beverley Hospital 11 4.3
Boston Medical Center 46 18.0
Brigham and Women’s Hospital 44 17.3
Cambridge Health Alliance 16 6.3
Mass General Hospital 48 18.8
Newton Wellesley Hospital 6 2.4
Tufts Medical Center 5 2.0
UMass Memorial Medical Center 23 9.0
Winchester Hospital 5 2.0
Total 255 100%
Month of birth, n (%)
  March 17 6.7
  April 79 31.0
  May 88 34.5
  June 55 21.6
  July 16 6.3
Maternal demographics
 Age, mean (SD) 30.4 6.3
Race/ethnicity, n (%)
  Hispanic (any race) 123 48.2
  Non-Hispanic White 50 19.6
  Non-Hispanic Black 48 18.8
  Non-Hispanic Asian 14 5.5
  Non-Hispanic Other 19 7.5
Maternal language, n (%)
  English 136 53.3
  Spanish 84 32.9
  Portuguese 12 4.7
  Other 23 9.0
Social vulnerability indexa themes; percentile ranking, mean (SD)
  Socioeconomic status 65.8 23.3
  Household composition 53.3 29.4
  Minority and language status 71.6 25.6
  Housing and transportation 71.5 22.0
  Overall 70.2 23.8
 Social vulnerability index overall >90th percentile, n (%) 68 26.7
Severity of maternal illness, n (%)
  Asymptomatic 174 68.2
  Symptomatic 81 31.8
  Sick at home before admission 57 70.4
  Required hospitalization for treatment of COVID-19 24 29.6
 Multiple gestation, n (%) 10 3.9
Disposition, n (%)
  Home 253 99.2
  Transfer 2 0.01
  Deaths 0 0
Infant characteristics
 Liveborn, n (%) 255 100.0
 Gestational age, weeks, mean (SD) 37.9 2.6
 Birthweight, grams, mean (SD) 3116.3 655.6
 Female sex, n (%) 131 51.4
Disposition
  Home 247 96.9
  Transfer 7 2.8
  Died 1 0.4
 Any SARS-CoV-2 test during the newborn hospitalization, n (%) 225 88.2
  Any positive newborn test (among tested) 5 2.2
 Any SARS-CoV-2 test during the 30 days post-dischargeb, n (%) 7 4.6
  Any positive newborn test (among tested) 1 14.3
Positive SARS-CoV-2 test during the hospitalization or 30 days post-dischargeb
  Any positive newborn test (overall) 6 2.4
  Any positive newborn test (among tested) 6 2.7
Main Outcomes
Mode of delivery, n (%)
  Vaginal 142 55.7
  Cesarean birth 113 44.3
 Preterm (<37 weeks), n (%) 53 20.8
  Spontaneous or augmented following initiation of labor 15 28.3
  Medically-indicated 38 71.7
Location of care, n (%)
  Any rooming-in 167 65.5
  Complete separation during entire hospital course 88 34.5
 Any direct breastfeeding during the hospitalization 152 59.6

aSocial vulnerability index uses 15 US census variables derived from zip codes and was derived by the Centers of Disease Control.

bAmong 151 infants with 1 or more encounter.

The relationships between our main outcomes and maternal illness severity and social factors are shown in Table 3. Symptomatic SARS-CoV-2 infection was associated with increased cesarean and preterm delivery and decreased rooming-in and direct breastfeeding, compared to asymptomatic infection (p < 0.05). There were no significant relationships between social factors and our main outcomes, apart from language status, where we found that non-English speaking mothers had higher rates of preterm delivery (25%), compared to English speaking mothers (17%) (p = 0.03).

Table 3.

Main outcomes according to severity of maternal illness and social factors.

Severity of Maternal Illness Social Factors
Underrepresented Minority Status Language Status Socially Vulnerability Index
Asymptomatic n = 174 Symptomatic n = 81 p valuea Not URM n = 84 URMb n = 171 p valuea English n = 136 Not-English speaking n = 119 p valuea SVI < 90%tile n = 187 SVI ≥ 90%tile n = 68 p valuea
N (%) N (%) N (%) N (%)
Outcome measures
Mode of delivery
 Vaginal 108 (62.1) 34 (42.0) 0.02 42 (50.0) 100 (58.5) 0.08 72 (52.9) 70 (58.8) 0.397 106 (56.7) 36 (52.9) 0.620
 Cesarean section 66 (37.9) 47 (58.0) 42 (50.0) 71 (41.5) 64 (47.1) 49 (41.2) 81 (43.3) 32 (47.1)
Preterm birth <37 weeks
 Yes 21 (12.1) 32 (39.5) <0.001 14 (16.7) 39 (22.8) 0.146 23 (16.9) 30 (25.2) 0.026 39 (20.9) 14 (20.6) 0.927
 No 153 (87.9) 49 (60.5) 70 (83.3) 132 (77.2) 113 (83.1) 89 (74.8) 148 (79.1) 54 (79.4)
Location of care
 Any rooming-in 136 (78.2) 31 (38.3) <0.001 57 (67.9) 110 (64.3) 0.490 92 (67.7) 75 (63.0) 0.836 125 (66.8) 42 (61.8) 0.164
 Complete separation 38 (21.8) 50 (61.7) 27 (32.1) 61 (35.7) 44 (32.3) 44 (37.0) 62 (33.2) 26 (38.2)
Breastfeedingc
 Any direct breastfeeding 124 (71.3) 28 (34.6) <0.001 54 (64.3) 98 (57.3) 0.361 78 (57.3) 74 (62.2) 0.698 116 (62.0) 36 (52.9) 0.200
 No direct breastfeeding 50 (28.7) 53 (65.4) 30 (35.7) 73 (42.7) 58 (42.7) 45 (37.8) 71 (38.0) 32 (47.1)

URM underrepresented minority.

ap value accounts for hospital clustering using Cochran-Mantel-Haenszel chi-square tests.

bNon-Hispanic black or Hispanic of any race.

cp value additionally accounts for clustering by multiples.

Control chart analysis of our main outcomes from March until July (Fig. 1) showed that cesarean delivery decreased from 49 to 35%, rooming-in increased from 55 to 86%, any direct breastfeeding increased from 53 to 72%, and preterm delivery did not change. We did not see differences in time trends according to maternal race/ethnicity, language status or SVI (Figs. 25).

Fig. 3. URM = underrepresented minority (non-Hispanic black or Hispanic of any race); average percent of preterm delivery (<37 weeks) over time according to maternal.

Fig. 3

A severity of illness, B race/ethnicity, C language status, and D social vulnerability index are shown.

Fig. 4. URM = underrepresented minority (non-Hispanic black or Hispanic of any race); average percent of any rooming in during the newborn hospitalization over time according to maternal.

Fig. 4

A severity of illness, B race/ethnicity, C language status, and D social vulnerability index are shown.

Fig. 1. AAP = American Academy of Pediatrics; CDC = Centers for Disease Control; SMFM = Society for Maternal Fetal Medicine; BF = breastfeeding; Results of 255 mothers with positive SARS-CoV-2 testing between 14 days before until 3 days after delivery at 11 Massachusetts birthing hospitals that gave birth from March 1 to July 31, 2020.

Fig. 1

Average percent of A cesarean delivery, B preterm delivery (<37 weeks), C any rooming-in, and D any direct breastfeeding are shown over time with 2 standard deviations. Red stars represent dates of newborn-oriented webinars and orange stars represent dates of obstetric-oriented webinars.

Fig. 2. URM = underrepresented minority (non-Hispanic black or Hispanic of any race); average percent of cesarean delivery over time according to maternal.

Fig. 2

A severity of illness, B race/ethnicity, C language status, and D social vulnerability index are shown.

Fig. 5. URM = underrepresented minority (non-Hispanic black or Hispanic of any race); average percent of any direct breastfeeding during the newborn hospitalization over time according to maternal.

Fig. 5

A severity of illness, B race/ethnicity, C language status, and D social vulnerability index are shown.

Discussion

The majority of birthing hospitals in Massachusetts participated in a perinatal quality initiative focused on care of mothers with SARS-CoV-2 infection and their infants during the initial surge of the pandemic. Data from 255 mother-infant dyads collected at 11 centers that cared for patients living in cities with the highest proportion of COVID-19 in Massachusetts demonstrated that rates of cesarean delivery significantly decreased and rates of rooming-in and direct breastfeeding significantly increased from March to July 2020. While SARS-CoV-2 infection disproportionately affected URM, non-English, and socially vulnerable mothers, we did not find that these factors influenced how perinatal care practices changed over time during the health crisis. Hospital-level survey data showed that hospitals increasingly adopted a shared-decision making model for rooming-in and direct breastfeeding over time.

Our project highlights the strengths of leveraging statewide PQC infrastructure to support local hospitals during a public health crisis. PQCs are strongly endorsed by the Centers for Disease control and have rapidly grown in the past decade [23]. PQCs have been used for a wide array of clinical improvements and have been shown to be more effective than local site QI at facilitating sustained improvement [24, 25]. This likely occurs because PQCs provide an infrastructure for well-defined data collection and reporting, team sharing, and resources such as training in basic QI methods. In our case, Massachusetts perinatal hospital teams were accustomed to voluntary sharing of local improvement approaches, completing practice surveys, and contributing data to a central database, which existed as part of our PQC infrastructure. These resources allowed for rapid initiation and conduct of a quality initiative focused on perinatal SARS-CoV-2 hospital practices. A notable difference between this initiative and previous ones was the lack of knowledge regarding evidence-based perinatal practices associated with optimal health and well-being of mother-infant dyads with SARS-CoV-2 at the start of our initiative, which evolved over time. In contrast, previous initiatives have targeted adoption of hospital practices with a more robust evidence base. Instead, best practice was constantly being sought and shared collaboratively by the group. Overall, we believe that our project demonstrated the successful use of the PQC structure during the time of an uncertain health crisis, which expands upon the previously reported uses of PQCs, and further strengthens the rationale for policy support as well as funding to develop and maintain such organizations by diverse stakeholders vested in perinatal care.

We speculate that the rapid changes in perinatal care practices occurred for several reasons. First, we openly discussed emerging evidence and its implications on perinatal care at our webinars. For example, small case reports from China in March reported low rates of positive SARS-CoV-2 infant testing following cesarean delivery and immediate mother-infant separation [26, 27], however, by April, case series began to be published in Europe in which rates of positive SARS-CoV-2 infant testing was also low following vaginal delivery and rooming-in [28, 29]. By May and June, larger studies and reviews of multiple case series further affirmed that positive SARS-CoV-2 infant testing appeared to be low irrespective of delivery mode, location of care and/or direct breastfeeding [30, 31]. Second, at a webinar in May 2020, we reviewed cases of positive infant SARS-CoV-2 testing in Massachusetts. Similar to published literature [30, 31], infants with positive tests in our state appeared to be rare [20]. Third, we discussed professional guidelines, including discrepancies (e.g., AAP [32, 33], CDC [34, 35], and Society for Maternal Fetal Medicine [36]) extensively. The first official guidance by the SMFM was published on April 30 [36], which stated that COVID-19 was not an indication for delivery among asymptomatic and mildly symptomatic women and that mode of delivery should be based on routine indications. While decision making about mode of delivery is driven by many factors, we speculate that this SMFM guidance additionally contributed to the decrease in rates of cesarean deliveries we observed. The AAP and CDC guidance, while slightly different in emphasis, did not change during the project period. In April and May 2020, the AAP guidance recommended temporary separation of mothers and infants as the safest course of action if possible and the CDC recommended use of a shared-decision making approach for location of care and direct breastfeeding. Our monthly hospital practice surveys showed increased adoption of the shared-decision making approach between April and June 2020; we hypothesize that this additionally contributed to increases in rooming-in and direct breastfeeding. Overall, we speculate that review of emerging literature, Massachusetts cases and evolving professional organization guidance helped build consensus regarding best practices and led to the rapid implementation of such practices.

We found alarming social disparities among mothers with SARS-CoV-2 infection, similar to previous US studies [37]. As we have done in our previous work [6], we assessed our outcomes as a function of several social factors to determine if these factors influenced perinatal care practices. Although social factor subgroups were small, we were reassured to see that changes in perinatal practices did not vary by social factors. Nonetheless, we recognize that unconscious racial/ethnic and other social biases toward patients by health care providers occur [38] and that implementing strategies to address social disparities in SARS-CoV-2 infection and vaccination are crucial.

Strengths of our quality initiative include use of both practice surveys and tracking of individual-level dyads among centers serving a large proportion of communities with COVID-19 to assess changes in perinatal hospital practice outcomes over time. We also tracked outcomes by several social factors to assess equity in care. Because of the rapid changes and relatively short duration of this initiative, we were unable to track detailed accounts of plan-do-study-act cycles by teams. Further, we tracked outcomes of mothers with positive SARS-CoV-2 testing around the time of birth only, such that we were unable to capture outcomes of mothers with positive SARS-CoV-2 testing earlier in pregnancy. We did not obtain data on patient reported measures, which may have yielded more information about families’ experiences during the perinatal hospitalization.

Conclusion

We successfully leveraged our existing PQC structure to disseminate emerging data and build consensus to inform rapid, statewide changes in COVID-19 perinatal practices, suggesting a novel use of PQCs during health crises when best practices are uncertain and quickly evolving. We found that an initial highly protective strategy of cesarean delivery with maternal-infant separation and temporary avoidance of direct breastfeeding gradually transitioned to a decrease in cesarean delivery and increase in rooming-in and direct breastfeeding. Our experience further strengthens the rationale for policy support and funding for PQCs at the state-level. Because perinatal care quality may vary by social factors, which may widen or persist with quality improvement interventions, we proactively examined changes in perinatal care practices according to social factors to monitor for any potential inequities. While tracking of social factors in perinatal quality improvement still remains uncommon, it is crucial to do so in order to address the potential for social inequities in perinatal care delivery.

Acknowledgements

We wish to thank all the participating teams and state stakeholders of the Perinatal Neonatal Quality Improvement Collaborative of Massachusetts. This was supported in part by W.K. Kellogg Foundation (PI Parker; P0131665). The funder/sponsor did not participate in this work.

Author contributions

Parker and Sullivan drafted the original manuscript, conceived and designed the study, and contributed to data acquisition and analysis. Belfort, Melvin, Angelidou conceived and designed the study, contributed to data acquisition and analysis, preparation of the manuscript. Peaceman and Shui, Vaidya, Singh, Bartolome, Patrizi, Culic, Yanni, Chaudhary, and Goldfarb contributed to data acquisition and analysis; reviewed and revised the manuscript for intellectual content. Gupta and Hudak critically reviewed and revised the manuscript for important intellectual content. All authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work.

Competing interests

The authors declare no competing financial interests.

Footnotes

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References


Articles from Journal of Perinatology are provided here courtesy of Nature Publishing Group

RESOURCES